Clinical Trial

Essen Amyloidosis Registry

Study acronym: EAR
Recruiting
View on ClinicalTrials.gov →
Summary
The Essen Amyloidosis Registry (EAR) is a prospective, observational registry designed to collect comprehensive clinical data on patients diagnosed with systemic amyloidosis. The registry aims to improve the understanding of disease progression, diagnostic pathways, and treatment outcomes. The registry is hosted at the University Hospital Essen and follows patients longitudinally. Inclusion is open to all patients with suspected or confirmed amyloidosis who provide informed consent.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-14.
Trial Details
NCT Number NCT06887283
Lead Sponsor University Hospital, Essen
Conditions Amyloidosis; Systemic, Amyloidosis Cardiac
Enrollment 400 participants
Start Date 2024-05-08
Primary Completion 2029-01-01 (estimated)
Study Completion 2029-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-21